RTI International Research Publications

For general information about RTI publications, contact:

Publication Bibliography

1 - 11 of 11 research publications assigned to the bibliography Irritable Bowel Syndrome are currently in the database.

Sort by:

Limited to:

Journal Article (83)

Williams, R., Black, C., Kim, H., Andrews, E.B., Mangel, A.W., Buda, J.J., & et al. (Jan 2006).
Stability of irritable bowel syndrome using a Rome II-based classification.
Alimentary Pharmacology and Therapeutics, 23 (1):197-205.

Andrews, E.B., Eaton, S.C., Hollis, K.A., Hopkins, J.S., Ameen, V.Z., Hamm, L.R., & et al. (2005).
Prevalence and demographics of irritable bowel syndrome: results from a large web-based survey.
Alimentary Pharmacology and Therapeutics, 2005 (22):935-942.

Leventer, S., Raudibaugh, K., Mangel, A.W., Galbraith, K., Kucharik, R., Ye, N.D., & et al. (2005).
Dextofisopam improves bowel function in men and women with IBS.
American Journal of Gastroenterology, 100 (9):S344-S344.

Mangel, A.W. (2004 Jan).
Study design issues in irritable bowel syndrome.
Alimentary Pharmacology and Therapeutics, 19 (1):141-142.

Mayer, E.A., Berman, S., Derbyshire, S.W., Suyenobu, B., Chang, L., Fitzgerald, L., Mandelkern, M., & et al. (2002 Jul).
The effect of the 5-HT3 receptor antagonist, alosetron, on brain responses to visceral stimulation in irritable bowel syndrome patients.
Alimentary Pharmacology and Therapeutics, 16 (7):1357-1366.

Camilleri, M., Chey, W.Y., Mayer, E.A., Northcutt, A.R., Heath, A., Dukes, G.E., & et al. (2001 Jul 23).
A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome.
Archives of Internal Medicine, 161 (14):1733-1740.

Watson, M.E., Lacey, L., Kong, S., Northcutt, A.R., McSorley, D., Hahn, B., & et al. (2001 Feb).
Alosetron improves quality of life in women with diarrhea-predominant irritable bowel syndrome.
American Journal of Gastroenterology, 96 (2):455-459.

Camilleri, M., Northcutt, A.R., Kong, S., Dukes, G.E., McSorley, D., & Mangel, A.W. (2000 Mar 25).
Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial.
Lancet, 355 (9209):1035-1040.

Camilleri, M., Mayer, E.A., Drossman, D.A., Heath, A., Dukes, G.E., McSorley, D., & et al. (1999 Sep).
Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist.
Alimentary Pharmacology and Therapeutics, 13 (9):1149-1159.

Hamm, L.R., Sorrells, S.C., Harding, J.P., Northcutt, A.R., Heath, A.T., Kapke, G.F., & et al. (1999 May).
Additional investigations fail to alter the diagnosis of irritable bowel syndrome in subjects fulfilling the Rome criteria.
American Journal of Gastroenterology, 94 (5):1279-1282.